An ongoing dialogue on HIV/AIDS, infectious diseases,
June 8th, 2009
H1N1: A Tale of Two Practices
As an adult ID/HIV doctor, I must say the clinical impact of H1N1 thus far has been underwhelming, notable more for the calls about prophylaxis or suspected cases than the real thing.
(Last week, one patient with fever and “suspected swine” — hard for people to shake that name — turned out to have … Lyme disease. Ah, New England in June.)
But for my wife, the pediatrician? There’s a full-blown epidemic out there, with outpatient visit volumes way up, and nearly continuous oseltamivir prophylaxis among her staff. As in mid-winter, she and her practice partners are routinely making the influenza diagnosis based on symptoms alone.
And while this report suggests the age cut-off for partial immunity to H1N1 is 60, I suspect strongly — based on our highly-anecdotal, two-doctor-family, completely non-scientific observation — that it’s going to turn out to be quite a bit younger.
Paul E. Sax, MD
Contributing Editor
NEJM Journal Watch
Infectious Diseases
Biography | Disclosures | Summaries
Learn more about HIV and ID Observations.
NEJM Journal Watch — Recent Infectious Disease Articles- Sulopenem Etzadroxil plus Probenecid (Orlynvah) for Uncomplicated Urinary Tract Infections
- Radiolabeled p-Aminobenzoic Acid as a Marker to Detect Bacterial Endocarditis
- Clostridioides difficile Vaccines: Promising Contenders
- Observations from ID and Beyond: Marking a Social Media Mass Migration — Until the Next One
- Incidence of Autoimmune Diseases Involving the Skin, After Acute COVID-19